Unknown

Dataset Information

Post-transplant immunosuppression and COVID-19: From a double whammy to a mixed blessing.


ABSTRACT: The coronavirus pandemic (COVID-19) has had an unprecedented effect on various disease processes and their management. COVID-19 is likely to have a complex pathophysiological interplay with the post-transplant patients; one affecting the clinical course and outcome of the other. In the absence of validated data from trials, there is strong dependence on experience based on previous similar epidemics (SARS/MERS), and from consensus based on expert opinions. Despite the fact that our knowledge is rapidly evolving with time, there still is relatively limited objective data on the effect of COVID-19 on the human body. Numerous questions remain unanswered, one of which involves the management of immunosuppression in the post-transplant recipient during this contagion. The core tenet of which co

SUBMITTER: Rammohan A 

PROVIDER: S-EPMC7504191 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature